The FDA has approved Amgen’s osteoporosis drug denosumab for use by cancer patients with solid tumors whose disease has metastasized to their bones. The indication to prevent complications such as fractures and bone pain among those patients could boost the drug’s sales by billions.
Continue reading Amgen’s Denosumab Approved for Cancer Patients
Amgen’s Denosumab Approved for Cancer Patients originally appeared on DailyFinance on Fri, 19 Nov 2010 13:24:00.
Filed Under: Company News, Health Care, Novartis, Amgen, Stocks in the News